Whois & Analysis for jardiance.com

Empagliflozin (trade name Jardiance) is a drug of the gliflozin class, approved for the treatment of type 2 diabetes in adults in 2014.

It was developed by Boehringer Ingelheim and Eli Lilly and Company.

Diabetes mellitus type 2 (also known as type 2 diabetes) is a long term metabolic disorder that is characterized by high blood sugar, insulin resistance, and relative lack of insulin.

Common symptoms include increased thirst, frequent urination, and unexplained weight loss.

Symptoms may also include increased hunger, feeling tired, and sores that do not heal.

Often symptoms come on slowly.

Long-term complications from high blood sugar include heart disease, strokes, diabetic retinopathy which can result in blindness, kidney failure, and poor blood flow in the limbs which may lead to amputations.

The sudden onset of hyperosmolar hyperglycemic state may occur; however, ketoacidosis is uncommon.

The blood sugar concentration or blood glucose level is the amount of glucose (sugar) present in the blood of a human or animal.

The body naturally tightly regulates blood glucose levels as a part of metabolic homeostasis.

Drugs used in diabetes treat diabetes mellitus by lowering glucose levels in the blood.

With the exceptions of insulin, exenatide, liraglutide and pramlintide, all are administered orally and are thus also called oral hypoglycemic agents or oral antihyperglycemic agents.

There are different classes of anti-diabetic drugs, and their selection depends on the nature of the diabetes, age and situation of the person, as well as other factors.

In nutrition, diet is the sum of food consumed by a person or other organism.

The word diet often implies the use of specific intake of nutrition for or reasons (with the two often being related).

Although humans are omnivores, each culture and each person holds some food preferences or some food taboos.

This may be due to personal tastes or ethical reasons.

Individual dietary choices may be more or less healthy.